OBJECTIVES: The objectives of this study were to determine whether the expr
ession of the interleukin-2 (IL-2) receptors on squamous cell carcinoma cel
ls can be enhanced in the presence of selenium (Se) and contribute to a gre
ater retardation of tumor growth after lacoregional therapy with IL-2.
STUDY DESIGN: The growth of the cells was studied after in vitro or dietary
supplementation with Se in a murine model.
RESULTS: Treatment of established tumors in hosts supplemented with Se with
peritumoral injections of IL-2 resulted in 50% reduction of tumor size, wh
ereas treatment of early tumors resulted in 72.4% reduction. The effect was
most likely related to a combination of enhanced immune responsiveness and
: enhanced IL-2 receptor expression on the tumor cells.
CONCLUSIONS AND SIGNIFICANCE: The data suggested that local immunotherapy w
ith IL-2 in hosts supplemented with Se may represent an effective modality
of treatment for the prevention of recurrences at the site of conventionall
y treated primary tumors, including tumors that do not express IL-2 recepto
rs.